We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
REGN icon
26
Regeneron Pharmaceuticals
REGN
$78.5B
$78.5B $762.58 0.44%
CI icon
27
Cigna
CI
$72.9B
$72.9B $275.80 2.22%
BSX icon
28
Boston Scientific
BSX
$70.7B
$70.7B $48.77 0.7%
COR icon
29
Cencora
COR
$59.6B
$59.6B $306.30 0.67%
CAH icon
30
Cardinal Health
CAH
$54.7B
$54.7B $233.47 0.9%
TAK icon
31
Takeda Pharmaceutical
TAK
$53.1B
$53.1B $16.63 1.19%
ARGX icon
32
argenx
ARGX
$52.9B
$52.9B $844.95 1.7%
EW icon
33
Edwards Lifesciences
EW
$51.3B
$51.3B $89.07 0.28%
IDXX icon
34
Idexx Laboratories
IDXX
$46.9B
$46.9B $594.93 4.77%
BDX icon
35
Becton Dickinson
BDX
$46.7B
$46.7B $169.60 0.36%
HUM icon
36
Humana
HUM
$43.7B
$43.7B $363.62 2.91%
HLN icon
37
Haleon
HLN
$42.9B
$42.9B $9.74 0.61%
RVMD icon
38
Revolution Medicines
RVMD
$40.9B
$40.9B $192.56 5.54%
TEVA icon
39
Teva Pharmaceuticals
TEVA
$40B
$40B $34.32 0.41%
NTRA icon
40
Natera
NTRA
$39.4B
$39.4B $275.09 1.75%
A icon
41
Agilent Technologies
A
$39.2B
$39.2B $138.94 0.62%
WAT icon
42
Waters Corp
WAT
$38.7B
$38.7B $394 5.14%
IQV icon
43
IQVIA
IQV
$37.6B
$37.6B $228.73 1.98%
MDLN
44
Medline Inc
MDLN
$34.9B
$34.9B $41.28 2%
ALC icon
45
Alcon
ALC
$34.5B
$34.5B $70.82 0.87%
VEEV icon
46
Veeva Systems
VEEV
$34.3B
$34.3B $211.03 2.32%
ONC
47
BeOne Medicines Ltd
ONC
$33.4B
$33.4B $321.45 2.45%
DXCM icon
48
DexCom
DXCM
$32.9B
$32.9B $87.23 0.09%
RMD icon
49
ResMed
RMD
$32.2B
$32.2B $221.95 3.14%
ZTS icon
50
Zoetis
ZTS
$31.9B
$31.9B $76.14 1.25%
1
2
3 4 5

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,066 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $8.94T.

The largest by market cap are Eli Lilly (LLY) at $998B, Johnson & Johnson (JNJ) at $613B and AbbVie (ABBV) at $430B.

Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.

  • Combined market cap: $8.94T across 1,066 stocks.
  • Largest constituent: Eli Lilly (LLY), $998B market cap.
  • Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.